Kodiak Sciences Inc.
KOD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.09 | 0.03 | -0.05 | -0.04 |
| FCF Yield | -22.50% | -122.76% | -67.85% | -27.96% |
| EV / EBITDA | -2.85 | 0.19 | -0.84 | -0.88 |
| Quality | ||||
| ROIC | -58.28% | -60.66% | -53.85% | -31.51% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.67 | 0.59 | 0.62 | 0.68 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 39.82% | 22.93% | -3.36% | -171.57% |
| Safety | ||||
| Net Debt / EBITDA | 0.65 | 0.87 | 0.32 | 2.52 |
| Interest Coverage | 0.00 | -21,332.38 | -18,965.50 | -12,138.68 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -53.51 | -191.43 | -302.92 | -520.87 |